Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 Apr 2024
Historique:
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: ppublish

Résumé

Little is known regarding differences in childhood growth between somatic and heritable retinoblastoma (Rb) populations. We aimed to compare childhood growth parameters between somatic and heritable Rb cohorts at birth and at time of diagnosis with Rb. A multinational, longitudinal cohort study was conducted with patients from 11 centers in 10 countries who presented with treatment naïve Rb from January to December 2019. Variables of interest included age, sex, and size characteristics at birth and at time of presentation, as well as germline mutation status. After Bonferroni correction, results were statistically significant if the P value was less than 0.005. We enrolled 696 patients, with 253 analyzed after exclusion criteria applied. Between somatic (n = 39) and heritable (n = 214) Rb cohorts, with males and females analyzed separately, there was no significant difference in birth weight percentile, weight percentile at time of diagnosis, length percentile at time of diagnosis, weight-for-length percentile at time of diagnosis, or change of weight percentile from birth to time of diagnosis. Patients with heritable Rb had a smaller mean weight percentile at birth and smaller mean weight and length percentiles at time of diagnosis with Rb, although this difference was not statistically significant. All cohorts experienced a slight negative change of weight percentile from birth to time of diagnosis. No cohort mean percentiles met criteria for failure to thrive, defined as less than the 5th percentile. Children with Rb seem to have normal birth and childhood growth patterns. There is no definitive evidence that somatic or heritable Rb has a biological or environmental impact on childhood growth parameters.

Identifiants

pubmed: 38662390
pii: 2793608
doi: 10.1167/iovs.65.4.39
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

39

Auteurs

Roxana M Hicks (RM)

Department of Ophthalmology, University of Washington, Seattle, Washington, United States.
Department of Medicine, University of Washington, Seattle, Washington, United States.

Xunda Ji (X)

Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Yihua Zou (Y)

Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Sadia Sultana (S)

Department of Oculoplasty and Ocular Oncology, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh.

Riffat Rashid (R)

Department of Oculoplasty and Ocular Oncology, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh.

Sadik T Sherief (ST)

Department of Ophthalmology, Addis Ababa University, Addis Ababa, Ethiopia.

Nathalie Cassoux (N)

Department of Ophthalmology, Institut Curie, Université de Paris Medicine Paris V Descartes, Paris, France.

Juan L Garcia Leon (JL)

Anglo American Clinic, Lima, Perú.

Rosdali Y Diaz Coronado (RY)

Instituto Nacional de Enfermedades Neoplasicas, Lima, Perú.

Arturo M Z López (AMZ)

Instituto Nacional de Enfermedades Neoplasicas, Lima, Perú.

Tatiana L Ushakova (TL)

Head and Neck Tumors Department, SRI of Pediatric Oncology and Hematology, N.N. Blokhin National Medical Research Center, Oncology of Russian Federation, Moscow, Russia.
Medical Academy of Postgraduate Education, Moscow, Russia.

Vladimir G Polyakov (VG)

Head and Neck Tumors Department, SRI of Pediatric Oncology and Hematology, N.N. Blokhin National Medical Research Center, Oncology of Russian Federation, Moscow, Russia.
Medical Academy of Postgraduate Education, Moscow, Russia.

Soma R Roy (SR)

Chittagong Eye Infirmary & Training Complex, Chittagong, Bangladesh.

Alia Ahmad (A)

The Children's Hospital and the Institute of Child Health, Lahore, Pakistan.

M Ashwin Reddy (MA)

The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.

Mandeep S Sagoo (MS)

The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
UCL Institute of Ophthalmology, London, United Kingdom.

Lamis Al Harby (L)

The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.

Jesse L Berry (JL)

The Vision Center, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, United States.
USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, United States.

Ashley Polski (A)

The Vision Center, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, United States.
USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, United States.

Nicholas J Astbury (NJ)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Covadonga Bascaran (C)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Sharon Blum (S)

Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.

Richard Bowman (R)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Ophthalmology Department, Great Ormond Street Children's Hospital, London, United Kingdom.

Matthew J Burton (MJ)

UCL Institute of Ophthalmology, London, United Kingdom.
International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Nir Gomel (N)

Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Naama Keren-Froim (N)

Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.

Shiran Madgar (S)

Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.

Marcia Zondervan (M)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Swathi Kaliki (S)

The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.

Ido D Fabian (ID)

International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.

Andrew W Stacey (AW)

Department of Ophthalmology, University of Washington, Seattle, Washington, United States.
Division of Ophthalmology, Seattle Children's Hospital, Seattle, Washington, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH